SCHEMBL9560019

SCHEMBL9560019

COC(=O)CNC(=O)CCS

nearest known ligand 0.69

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
RECQL P46063 1/20 0.69
TET2 Q6N021 1/20 0.48
TSHR P16473 6/20 0.46
HSD17B10 Q99714 2/20 0.46
GAA P10253 4/20 0.46
KDM4E B2RXH2 2/20 0.38
EPHX2 P34913 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
MGAM O43451 1/20 0.36
SI P14410 1/20 0.36
MGAM2 Q2M2H8 1/20 0.36
THRB P10828 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
BIRC2 Q13490 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13444980 0.82 RECQL (0.61) RECQLTET2TSHRHSD17B10GAA
SCHEMBL29648539 0.82 RECQL (0.75) RECQLTET2TSHRHSD17B10GAA
SCHEMBL40480 0.82 GAA (0.70) RECQLTSHRGAAEPHX2SMN1; SMN2
SCHEMBL27314945 0.81 RECQL (0.45) RECQLTSHRHSD17B10GAA
SCHEMBL810809 0.80 RECQL (0.72) RECQLTET2TSHRHSD17B10GAA
SCHEMBL23085256 0.78 RECQL (0.83) RECQLTET2TSHRHSD17B10GAA
SCHEMBL22345240 0.78 RECQL (0.69) RECQLTET2TSHRHSD17B10GAA
SCHEMBL23135463 0.78 RECQL (0.69) RECQLTET2TSHRHSD17B10GAA
SCHEMBL2754583 0.78 RECQL (0.69) RECQLTET2TSHRHSD17B10GAA
SCHEMBL18753028 0.78 RECQL (0.69) RECQLTET2TSHRHSD17B10GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021255156-A1 NOVEL DIPEPTIDE COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF AND A NOVEL THERAPEUTIC USE OF DIPEPTIDE COMPOUNDS Universite Paris-Saclay (FR) 2021-12-23 WO disclosed
EP-0358240-B1 INTERMEDIATES FOR THE PREPARATION OF LEUKOTRIENE ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1993-06-09 EP disclosed
US-5189226-A Chemical intermediate for diacid SMITHKLINE BEECHAM CORPORATION (US) 1993-02-23 US disclosed
US-5034537-A Alpha-methyl-4-halobenzenemethanamine salts of acids for cardiovascular disorders, respiratory system disorders and antiallergens SMITHKLINE BEECHAM CORPORATION (US) 1991-07-23 US disclosed
EP-0170048-B1 ALIPHATIC THIOETHERS CIBA-GEIGY AG (CH) 1991-04-17 EP disclosed
US-4939279-A Leukotriene antagonists SMITHKLINE BEECHAM CORPORATION (US) 1990-07-03 US disclosed
US-4937253-A LEUKOTRIENE ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1990-06-26 US disclosed
EP-0202759-B1 LEUKOTRIENE ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1990-06-20 EP disclosed
EP-0365149-A2 Leukotriene antagonist prodrugs SMITHKLINE BEECHAM CORPORATION (US) 1990-04-25 EP disclosed
EP-0358240-A2 Intermediates for the preparation of leukotriene antagonists SMITHKLINE BEECHAM CORPORATION (US) 1990-03-14 EP disclosed
US-4874792-A RESPIRATORY SYSTEM DISORDERS SMITHKLINE BECKMAN CORPORATION (US) 1989-10-17 US disclosed
US-4820719-A ANTIALLERGENS, ANTIINFLAMMATORY, ANTIISCHEMIC AND HYPOTENSIVE AGENTS SMITHKLINE BECKMAN CORPORATION (US) 1989-04-11 US disclosed
US-4649215-A ANTIALLERGENS CIBA-GEIGY CORPORATION (US) 1987-03-10 US disclosed
EP-0202759-A2 Leukotriene antagonists SMITHKLINE BEECHAM CORPORATION (US) 1986-11-26 EP disclosed
EP-0170048-A2 Aliphatic thioethers CIBA-GEIGY AG (CH) 1986-02-05 EP disclosed